This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of tinea pedis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Tinea confined to the toe webs:

  • topical creams such as an azole cream (e.g. miconazole cream used twice daily for four weeks) may be used. However evidence suggests that topical 1% terbinafine cream used for one week is the most effective topical antifungal available in the UK (1)
  • improved foot hygiene and drying between the toes (2)
  • if the tissue is inflamed then antifungal / topical steroid combinations may reduce symptoms more rapidly. However they have no overall benefit (3)

Systemic therapy and confirmation of diagnosis is appropriate for

  • more complex and multi-site infections (Moccasin pattern tinea).
  • associate toe nail infection (4)

The newer antifungals - oral imidazole or triazole antifungals (e.g. - itraconazole) and oral terbinafine are used more commonly than griseofulvin because they have a broader spectrum of activity and require a shorter duration of treatment (4)

  • for example itraconazole 200mg bd for 7 days or 100mg od for 30 days

Patients should avoid walking barefoot in communal places (5).

Reference:

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.